Skip to main content
. 2016 May 27;13(6):540. doi: 10.3390/ijerph13060540

Table 2.

Characteristics of metabolically healthy non-obese (MHNO), metabolically healthy obese (MHO), metabolically abnormal non-obese (MANO) and metabolically abnormal obese (MAO) subjects.

Characteristics MHNO
(n = 2500, 22.5%)
MHO
(n = 1009, 9.1%)
MANO
(n = 3567, 32.1%)
MAO
(n = 4051, 36.4%)
p Value a
Female (%) 1392 (55.7) 632 (62.6) 1759 (49.3) 2123 (52.4) <0.001
Age (years) 49.60 ± 9.54 48.11 ± 8.75 b 56.79 ± 10.34 b,c 54.26 ± 9.90 b,c,d <0.001
BMI (kg/m2) 22.05 ± 1.74 27.45 ± 2.65 b 22.57 ± 1.68 b,c 28.10 ± 2.64 b,c,d <0.001
WC (cm) 75.07 ± 6.39 86.41 ± 7.59 b 78.23 ± 6.87 b,c 90.15 ± 7.89 b,c,d <0.001
Current smoking (%) 920 (36.8) 258 (25.6) 1466 (41.1) 1271 (31.4) <0.001
Current drining (%) 523 (20.9) 183 (18.1) 919 (25.8) 934 (23.1) <0.001
Systolic BP (mmHg) 122.58 ± 10.04 125.18 ± 9.22 b 148.29 ± 22.69 b,c 151.80 ± 22.78 b,c,d <0.001
Diastolic BP (mmHg) 73.72 ± 7.36 75.89 ± 6.96 b 84.23 ± 11.47 b,c 87.06 ± 11.54 b,c,d <0.001
FBG (mmol/L) 5.27 ± 0.42 5.34 ± 0.42 6.06 ± 1.77 b,c 6.28 ± 1.96 b,c,d <0.001
TC (mmol/L) 4.87 ± 0.91 4.98 ± 0.93 b 5.30 ± 1.10 b,c 5.45 ± 1.11 b,c,d <0.001
TG (mmol/L) 0.95 ± 0.32 1.06 ± 0.32 b 1.66 ± 1.57 b,c 2.17 ± 1.77 b,c,d <0.001
LDL-C (mmol/L) 2.62 ± 0.68 2.82 ± 0.71 b 2.92 ± 0.82 b,c 3.15 ± 0.86 b,c,d <0.001
HDL-C (mmol/L) 1.50 ± 0.35 1.40 ± 0.31 b 1.46 ± 0.42 b,c 1.30 ± 0.34 b,c,d <0.001
Creatinine (μmol/L) 69.98 ± 11.85 68.90 ± 12.47 71.77 ± 14.00 b,c 72.55 ± 15.09 b,c,d <0.001
eGFR (mL/min/1.73 m2) 103.09 ± 29.11 103.41 ± 10.02 98.24 ± 43.18 b,c 98.59 ± 23.51 b,c <0.001
Mildly reduced eGFR (%) 225 (9.0) 71 (7.0) 805 (22.6) 840 (20.7) <0.001

Data are mean ± SD or number (%) MHNO metabolically health non-obese, MHO metabolically healthy obese, MANO metabolically abnormal obese, MAO metabolically abnormal obese, BMI body mass index, WC waist circumference, BP blood pressure, FBG fasting blood glucose, TC total cholesterol, TG triglyceride, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol. eGFR estimated glomerular filtration rate. a Difference between four groups; b p < 0.05 compared with MHNO group; c p < 0.05 compared with MHO group; d p < 0.05 compared with MANO group.